Evidence map›Paper›PMID 18586676›Full record

ArticleThe Journal of biological chemistry2008

The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase.

Agnès Mambole, Dominique Baruch, Patrick Nusbaum, Sylvain Bigot, Misa Suzuki, Philippe Lesavre, Minoru Fukuda, Lise Halbwachs-Mecarelli

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The many substrates of presenilin/γ-secretase.Journal of Alzheimer's disease : JAD · 2011
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Agnès MamboleINSERM U845, the Université René Descartes, Hôpital Necker, 161 Rue de Sèvres, Paris, France.
Dominique Baruch
Patrick Nusbaum
Sylvain Bigot
Misa Suzuki
Philippe Lesavre
Minoru Fukuda
Lise Halbwachs-Mecarelli
Délégation Paris 5 · FRCancer Research Center · USInserm · FRUniversité Paris Cité · FR

Funding

GLYCOPROTEINS IN DIFFERENTIATION AND ONCOGENESISR37CA033000 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI FUKUDA, MINORU · 1995 to 2004
$2.1M
GLYCOPROTEINS IN DIFFERENTIATION AND ONCOGENESISR01CA033000 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FUKUDA, MINORU · 1985 to 2009
$1.8M
NCI NIH HHS CA 33000NCI NIH HHS R01 CA033000
6 · The paper itself

Abstract

The highly negatively charged membrane sialoglycoprotein leukosialin, CD43, is shed during neutrophil activation. This is generally thought to enhance cell adhesion. We here describe two novel consequences of this shedding, during neutrophil activation by phorbol esters or by chemoattractants after TNF-alpha priming. CD43 proteolysis was investigated by Western blotting, using a polyclonal antibody to CD43 intracellular domain. Our data emphasize the importance of a juxtamembranous cleavage of about 50% of membrane CD43 molecules by cathepsin G. Indeed, it is inhibited by alpha1-antichymotrypsin and cathepsin G inhibitor I and is reproduced by exogenous purified cathepsin G. The resulting membrane-anchored C-terminal fragment, CD43-CTF, becomes susceptible to presenilin/gamma-secretase, which releases CD43 intracytoplasmic domain: preincubation with three different gamma-secretase inhibitors, before PMN treatment by agonists or by purified cathepsin G, results in the accumulation of CD43-CTF. Because CD43 binds E-selectin, we also investigated the effect of the soluble extracellular domain CD43s, released by cathepsin G juxtamembranous cleavage, on neutrophil adhesion to endothelial cells. A recombinant CD43s-Fc fusion protein inhibited neutrophil E selectindependent adhesion to endothelial cells under flow conditions, while it had no effect on neutrophil static adhesion. We thus propose that, in addition to its potential pro-adhesive role, CD43 proteolysis results in: (i) the release, by cathepsin G, of CD43 extracellular domain, able to inhibit the adhesion of flowing neutrophils on endothelial cells and thus to participate to the natural control of inflammation; (ii) the release and/or the clearance, by presenilin/gamma-secretase, of CD43 intracellular domain, thereby regulating CD43-mediated signaling.

Indexed as

Amyloid Precursor Protein SecretasesCathepsin GCathepsinsCell AdhesionEndothelial CellsE-SelectinHumansInflammationLeukosialinNeutrophil ActivationNeutrophilsPresenilinsProtease InhibitorsProtein Structure, TertiarySerine EndopeptidasesSignal TransductionAmyloid Precursor Protein SecretasesCathepsin GCathepsinsCTSG protein, humanE-SelectinLeukosialinPresenilinsProtease InhibitorsSerine EndopeptidasesSPN protein, human

Identifiers

PMID18586676
PMCPMC2527098
OpenAlexW1964617248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.